Access cutting-edge beta-thalassemia treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.
Access beta-thalassemia specialists in Cleveland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related beta-thalassemia treatment provided free
A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants: * Participants receiving luspatercept on a parent protocol at the time of their transition to the rollover study, who tolerate the protocol-prescribed regimen in the parent trial and, in the opinion of the investigator, may derive clinical benefit from continuing treatment with luspatercept * Participants in the follow-up phase previously treated with luspatercept
Sponsor: Celgene
Check if you qualify for this beta-thalassemia clinical trial in Cleveland, OH
If you're searching for beta-thalassemia treatment options in Cleveland, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced beta-thalassemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.